Cullen Frost Bankers Lowered Its Position in Abbvie Com (ABBV) by $1.36 Million; As Equifax (EFX) Share Price Rose, Shareholder Oakworth Capital Has Raised Stake

February 24, 2018 - By Adrian Erickson

Cullen Frost Bankers Inc decreased its stake in Abbvie Inc Com (ABBV) by 3.51% based on its latest 2017Q3 regulatory filing with the SEC. Cullen Frost Bankers Inc sold 15,414 shares as the company’s stock rose 6.17% with the market. The institutional investor held 423,931 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $37.67 million, down from 439,345 at the end of the previous reported quarter. Cullen Frost Bankers Inc who had been investing in Abbvie Inc Com for a number of months, seems to be less bullish one the $188.57B market cap company. The stock increased 1.01% or $1.19 during the last trading session, reaching $118.75. About 4.69M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 24, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Oakworth Capital Inc increased its stake in Equifax Inc (EFX) by 12660% based on its latest 2017Q3 regulatory filing with the SEC. Oakworth Capital Inc bought 6,330 shares as the company’s stock rose 4.79% with the market. The institutional investor held 6,380 shares of the finance company at the end of 2017Q3, valued at $909,000, up from 50 at the end of the previous reported quarter. Oakworth Capital Inc who had been investing in Equifax Inc for a number of months, seems to be bullish on the $13.86B market cap company. The stock increased 0.16% or $0.19 during the last trading session, reaching $115.4. About 1.30M shares traded or 8.53% up from the average. Equifax Inc. (NYSE:EFX) has risen 11.28% since February 24, 2017 and is uptrending. It has underperformed by 5.42% the S&P500.

Investors sentiment decreased to 0.71 in 2017 Q3. Its down 0.33, from 1.04 in 2017Q2. It worsened, as 131 investors sold EFX shares while 158 reduced holdings. 87 funds opened positions while 118 raised stakes. 108.40 million shares or 3.06% more from 105.18 million shares in 2017Q2 were reported. State Bank Of Nova Scotia Tru has invested 0% of its portfolio in Equifax Inc. (NYSE:EFX). Oregon Employees Retirement Fund reported 12,837 shares. Long Road Invest Counsel Ltd Liability Corporation invested in 0.53% or 7,000 shares. Employees Retirement Association Of Colorado reported 0.29% stake. Jefferies Ltd owns 169 shares. Daiwa Sb Invs Ltd reported 0.17% stake. Cibc Asset Management, Ontario – Canada-based fund reported 11,676 shares. Transamerica Advsr Inc owns 7 shares or 0% of their US portfolio. Bridgewater Associates Limited Partnership accumulated 54,250 shares. Winslow Evans & Crocker Inc accumulated 0.26% or 7,468 shares. Crawford Inv Counsel has 32,931 shares. Gideon Incorporated has invested 0.23% of its portfolio in Equifax Inc. (NYSE:EFX). Wellington Shields Capital Ltd Liability Com reported 6,660 shares or 0.09% of all its holdings. Schwab Charles Investment Inc holds 0.04% or 396,389 shares in its portfolio. Old Natl Bankshares In reported 63,229 shares.

Oakworth Capital Inc, which manages about $389.35M US Long portfolio, decreased its stake in Vanguard Growth Etf (VUG) by 2,659 shares to 2,839 shares, valued at $374,000 in 2017Q3, according to the filing.

Among 17 analysts covering Equifax Inc (NYSE:EFX), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. Equifax Inc had 58 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Friday, September 15 by Morgan Stanley. Robert W. Baird maintained Equifax Inc. (NYSE:EFX) on Tuesday, October 3 with “Buy” rating. Stifel Nicolaus downgraded the stock to “Hold” rating in Monday, November 13 report. The stock of Equifax Inc. (NYSE:EFX) has “Buy” rating given on Thursday, November 9 by Robert W. Baird. The stock has “Buy” rating by Stifel Nicolaus on Friday, September 8. Barclays Capital downgraded the stock to “Equal-Weight” rating in Thursday, December 14 report. The company was downgraded on Friday, January 20 by Goldman Sachs. The firm earned “Outperform” rating on Monday, December 5 by Robert W. Baird. The firm earned “Buy” rating on Friday, October 23 by Stifel Nicolaus. Wells Fargo maintained it with “Buy” rating and $127.0 target in Friday, October 6 report.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It dropped, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Hartline Investment holds 0.24% in AbbVie Inc. (NYSE:ABBV) or 8,775 shares. Stewart And Patten Ltd Liability Corporation has invested 0.25% in AbbVie Inc. (NYSE:ABBV). Endurance Wealth Mngmt holds 103,302 shares. Prudential stated it has 5.36M shares or 0.79% of all its holdings. E&G Advsr LP has invested 0.16% in AbbVie Inc. (NYSE:ABBV). Montgomery Investment Mgmt owns 20,090 shares. Hamlin Cap Management Ltd Liability Corp owns 2.89% invested in AbbVie Inc. (NYSE:ABBV) for 802,215 shares. Zeke Cap Advsrs Ltd Co holds 25,493 shares or 0.31% of its portfolio. City Holdings reported 41,986 shares. Old Natl Savings Bank In invested 1.27% in AbbVie Inc. (NYSE:ABBV). 10 has invested 0.57% in AbbVie Inc. (NYSE:ABBV). Grand Jean Cap Mngmt Incorporated has 0.36% invested in AbbVie Inc. (NYSE:ABBV) for 11,165 shares. 3.19 million were accumulated by Manufacturers Life Insur Co The. Williams Jones And Associates Ltd Co stated it has 55,164 shares or 0.12% of all its holdings. 82,450 were reported by Steinberg Global Asset.

Since September 11, 2017, it had 0 insider buys, and 6 selling transactions for $25.71 million activity. Michael Robert A. also sold $119,351 worth of AbbVie Inc. (NYSE:ABBV) on Monday, February 19. The insider Schumacher Laura J sold 145,510 shares worth $14.07 million. On Monday, December 18 the insider RICHMOND TIMOTHY J. sold $8.57 million. SALEKI-GERHARDT AZITA sold $705,655 worth of stock or 8,300 shares.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Cowen & Co given on Friday, July 28. The firm earned “Buy” rating on Friday, July 14 by Jefferies. Citigroup upgraded AbbVie Inc. (NYSE:ABBV) rating on Tuesday, February 23. Citigroup has “Buy” rating and $65 target. The stock has “Overweight” rating by Morgan Stanley on Monday, November 2. UBS maintained AbbVie Inc. (NYSE:ABBV) on Friday, October 23 with “Buy” rating. The firm has “Buy” rating given on Thursday, September 28 by Piper Jaffray. Jefferies upgraded AbbVie Inc. (NYSE:ABBV) on Monday, December 7 to “Buy” rating. BMO Capital Markets maintained AbbVie Inc. (NYSE:ABBV) rating on Wednesday, April 19. BMO Capital Markets has “Hold” rating and $63 target. The rating was maintained by BMO Capital Markets with “Hold” on Wednesday, October 11. Cowen & Co upgraded the stock to “Outperform” rating in Wednesday, October 11 report.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>